Ibandronat-Mepha 150 mg Monatstabletten
Ibandronat-Mepha 150 mg Monatstabletten is a medicine authorised by Swissmedic under authorisation number 61317. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 February 2011 and the authorisation is valid without a time limit. ATC code M05BA06 places the medicine in the group Drugs for treatment of bone diseases.
| Authorisation number | 61317 |
|---|---|
| Name | Ibandronat-Mepha 150 mg Monatstabletten |
| Full name | Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M05BA06 |
| First authorisation | 24 February 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten | B | 24 February 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 1 | Tablette(n) | M05BA06 | 07.99.0. | B |
| 4 | 3 | Tablette(n) | M05BA06 | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ibandronat-Mepha 150 mg Monatstabletten authorised in Switzerland?
Yes. Ibandronat-Mepha 150 mg Monatstabletten is authorised by Swissmedic under authorisation number 61317, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ibandronat-Mepha 150 mg Monatstabletten have?
Ibandronat-Mepha 150 mg Monatstabletten is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ibandronat-Mepha 150 mg Monatstabletten?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.